BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17158542)

  • 1. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.
    Lam JS; Breda A; Belldegrun AS; Figlin RA
    J Clin Oncol; 2006 Dec; 24(35):5565-75. PubMed ID: 17158542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and selection for clinical studies of patients with kidney cancer.
    Lam JS; Klatte T; Kim HL; Patard JJ; Breda A; Zisman A; Pantuck AJ; Figlin RA
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):235-62. PubMed ID: 17931881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in renal cell carcinoma.
    Shuch BM; Lam JS; Belldegrun AS; Figlin RA
    Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing concepts in the surgical management of renal cell carcinoma.
    Lam JS; Shvarts O; Pantuck AJ
    Eur Urol; 2004 Jun; 45(6):692-705. PubMed ID: 15149740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal cell carcinoma--diagnostic and therapeutic--update].
    Jacqmin D
    Bull Acad Natl Med; 2004; 188(1):27-35; discussion 35-7. PubMed ID: 15368923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing natural history of renal cell carcinoma.
    Pantuck AJ; Zisman A; Belldegrun AS
    J Urol; 2001 Nov; 166(5):1611-23. PubMed ID: 11586189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic models and algorithms in renal cell carcinoma.
    Lane BR; Kattan MW
    Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
    Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
    Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection.
    Breda A; Konijeti R; Lam JS
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):847-62. PubMed ID: 17555395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.
    Lam JS; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned in the surgical management of renal cell carcinoma.
    Sengupta S; Zincke H
    Urology; 2005 Nov; 66(5 Suppl):36-42. PubMed ID: 16194705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma.
    Margulis V; Master VA; Cost NG; Leibovich BC; Joniau S; Kuczyk M; Mulders PF; Kirkali Z; Wirth MP; Hirao Y; Rawal S; Chong TW; Wood CG
    Eur Urol; 2011 Oct; 60(4):673-83. PubMed ID: 21752533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.